邮箱:fangxy197@163.com
北京生物结构前沿研究中心卓越学者
2015.9-2019.6 西北农林科技大学生命科学学院 本科
2019.9-2025.12 南方科技大学生命科学学院 博士
通过生物物理学方法跨尺度研究EB病毒侵入机制
[1] SUN C#, XIE C#, FANG X Y#, et al. Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein-Barr Virus[J]. Adv Mater, 2025: e07012.(co-First Author)
[2] XIE C#, FANG X Y#, LIU Y T#, et al. Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition[J]. PLoS Pathog, 2025,21(7): e1013300.
[3] FANG X Y#, SUN C#, XIE C#, et al. Structure and Antigenicity of Kaposi's Sarcoma Associated Herpesvirus Glycoprotein B[J]. Adv Sci , 2025, 12(27):e2502231.(co-First Author)
[4] SUN C#, FANG X Y#, BU G L#, et al. Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization[J]. Cell Rep, 2025, 44(1): 115168. (co-First Author)
[5] ZHAO G X#, FANG X Y#, BU G L#, et al. Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection[J]. Cell Rep Med, 2024, 5(5): 101573. (co-First Author)
[6] Cong Sun#, Jia-Wen Yang#, Chu Xie#, Xin-Yan Fang#, et al. The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses. hLife, 2024, 2(3):141-146. (co-First Author)
[7] SUN C#, KANG Y F#, FANG X Y#, et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV[J]. Cell Host Microbe, 2023, 31(11):1882-1897 e1810. (co-First Author)